share_log

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Last Week's 11% Decline Must Have Disappointed Retail Investors Who Have a Significant Stake

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Last Week's 11% Decline Must Have Disappointed Retail Investors Who Have a Significant Stake

Landfar Bio-Medicine Co., Ltd(深交所代碼:000504)上週下跌11%,一定讓持有大量股份的散戶投資者失望
Simply Wall St ·  2023/05/08 21:12

Key Insights

主要見解

  • The considerable ownership by retail investors in Landfar Bio-medicine indicates that they collectively have a greater say in management and business strategy
  • A total of 5 investors have a majority stake in the company with 50% ownership
  • Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock
  • 散戶投資者對蘭德法爾生物醫藥公司的大量持股表明,他們在管理和商業戰略方面擁有更大的發言權
  • 共有5名投資者持有該公司50%的多數股權
  • 所有權研究,結合過去的業績數據,可以幫助您更好地瞭解股票的機會

A look at the shareholders of Landfar Bio-medicine Co., Ltd (SZSE:000504) can tell us which group is most powerful. The group holding the most number of shares in the company, around 42% to be precise, is retail investors. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

看看蘭德法爾生物醫藥股份有限公司(深交所股票代碼:000504)的股東,我們就知道哪個集團最有實力。持有該公司股份最多的群體,準確地說約為42%,是散戶投資者。換句話說,該集團將從他們對公司的投資中獲得最大(或損失最大)。

As a result, retail investors as a group endured the highest losses last week after market cap fell by CN¥430m.

其結果是,在市值縮水4.3億元人民幣後,散戶投資者作為一個整體上週遭受了最大的損失。

Let's delve deeper into each type of owner of Landfar Bio-medicine, beginning with the chart below.

讓我們從下面的圖表開始,更深入地研究蘭德法爾生物醫藥的每一種類型的所有者。

See our latest analysis for Landfar Bio-medicine

查看我們對蘭德法爾生物醫學的最新分析

ownership-breakdown
SZSE:000504 Ownership Breakdown May 9th 2023
深交所:000504所有權明細2023年5月9日

What Does The Institutional Ownership Tell Us About Landfar Bio-medicine?

關於蘭德法爾生物醫藥,機構所有權告訴了我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時,以基準來衡量自己,因此一旦一隻股票被納入主要指數,它們往往會對這只股票變得更加熱情。我們預計,大多數公司都會有一些機構登記在冊,特別是在它們正在增長的情況下。

Landfar Bio-medicine already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Landfar Bio-medicine, (below). Of course, keep in mind that there are other factors to consider, too.

蘭德法爾生物醫藥公司已經在股票登記處登記了機構。事實上,他們在該公司擁有可觀的股份。這可以表明該公司在投資界具有一定的公信力。然而,最好警惕依賴機構投資者帶來的所謂驗證。他們也一樣,有時也會犯錯。如果兩個大型機構投資者試圖同時拋售一隻股票,股價大幅下跌的情況並不少見。因此,查看蘭德法爾生物醫藥過去的盈利軌跡是值得的(見下圖)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SZSE:000504 Earnings and Revenue Growth May 9th 2023
深交所:2023年5月9日盈利和收入增長000504

Landfar Bio-medicine is not owned by hedge funds. Hunan Caixin Venture Capital Co. Ltd is currently the largest shareholder, with 26% of shares outstanding. For context, the second largest shareholder holds about 11% of the shares outstanding, followed by an ownership of 5.0% by the third-largest shareholder.

蘭德法爾生物醫藥公司並非由對沖基金所有。湖南財新創業投資有限公司是目前的第一大股東,持有26%的流通股。作為參考,第二大股東持有約11%的流通股,第三大股東持有5.0%的股份。

To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

為了讓我們的研究更有趣,我們發現,前5名股東控制著公司一半以上的股份,這意味著這一群體對公司的決策具有相當大的影響力。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.

雖然研究一家公司的機構持股可以增加你的研究價值,但研究分析師的建議以更深入地瞭解一隻股票的預期表現也是一個很好的做法。我們的資訊顯示,分析師沒有對該股進行任何報道,因此它可能鮮為人知。

Insider Ownership Of Landfar Bio-medicine

蘭德法爾生物醫藥的內部所有權

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司內部人的定義可能是主觀的,而且在不同的司法管轄區之間確實有所不同。我們的數據反映了個別內部人士,至少捕捉到了董事會成員。管理層最終要向董事會負責。然而,經理人擔任執行董事會成員並不少見,尤其是如果他們是創始人或首席執行官的話。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認為內部人持股是一件好事。然而,在某些情況下,這會讓其他股東更難讓董事會對決策負責。

We can see that insiders own shares in Landfar Bio-medicine Co., Ltd. It has a market capitalization of just CN¥3.4b, and insiders have CN¥91m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.

我們可以看到,內部人持有蘭德生物醫藥有限公司的股份,其市值僅為34億元人民幣,內部人士以自己的名義持有價值9100萬元的股票。有人會說,這表明股東和董事會之間的利益一致。但或許值得一查的是,這些內部人士是否一直在拋售。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a 42% stake in Landfar Bio-medicine. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公眾通常是個人投資者,他們持有蘭德法爾生物醫藥公司42%的股份。儘管這種規模的所有權可能不足以影響有利於他們的政策決定,但他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

私募股權所有權

With an ownership of 37%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

擁有37%股權的私募股權公司有能力在塑造專注於價值創造的公司戰略方面發揮作用。一些人可能會喜歡這樣,因為私人股本有時是讓管理層承擔責任的積極分子。但在其他時候,私募股權公司讓公司上市後,它們的股票都賣光了。

Private Company Ownership

私營公司所有權

We can see that Private Companies own 13%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們可以看到,私營公司擁有13%的已發行股份。僅從這一事實很難得出任何結論,因此值得調查一下誰擁有這些私營公司。有時,內部人士或其他關聯方通過一家獨立的私人公司擁有上市公司的股份。

Next Steps:

接下來的步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.

我發現看看到底是誰擁有一家公司是非常有趣的。但為了真正獲得洞察力,我們還需要考慮其他資訊。

I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.

我喜歡潛入更深的地方瞭解一家公司過去的表現。您可以訪問此互動圖過去的收益、收入和現金流,是免費的。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費有趣的公司名單。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數位是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間。這可能與全年的年度報告數位不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論